Zhi Yang, CEO of Fasikl, Speaks with the Star Tribune About New Brain-Machine Interface Research and AI Therapeutics

Bloomington’s Fasikl is looking to commercialize its AI-powered wristband treating essential tremor. The device just received FDA clearance.

(MINNEAPOLIS, The Minnesota Star Tribune) – Zhi Yang, CEO of Fasikl, recently spoke about the company’s journey from gaming technology to developing a groundbreaking medical device for essential tremor. He described the creation of the Felix™ NeuroAI™ Wristband: an AI-powered, non-invasive device that delivers electrical stimulation to alleviate hand tremors, offering a new therapeutic option for millions of people. He also shared his vision for the evolution of AI in advancing medical technologies to better treat diseases, defining AI therapeutics more broadly as scalable healthcare solutions with greater efficacy and improved safety.